Chris Bonnett

Contributor

Chris Bonnett, PhD, provides practical health policy research primarily for public and private drug plan leaders, and advises on strategies to improve health in the workplace. His 2020 doctorate focused on social insurance as a way to achieve universal drug insurance. He has made submissions to Health Canada, The House of Commons Standing Committee on Health, the Advisory Council on the Implementation of National Pharmacare, and CADTH (rare disease drug formulary). He established H3 Consulting after 18 years of progressive experience in employee benefits.

1 Contribution
by Chris Bonnett

An update on national pharmacare, and five steps to get us there faster

The current state of our health system means viable alternative approaches are needed. Private plans are not perfect, and neither are provincial plans. But both payer groups need to better protect Canadians from ruinous drug costs.

1 of 1